Novartis Egypt is fully dedicated to and committed to helping the community we operate in through our corporate responsibility initiatives, making sure we reach our target and support various causes. Our initiatives encompass patients assistance programs to facilitate access to treatment in oncology and general medicine, and community support initiatives, helping to improve the lives of our patients and residents in underprivileged areas.
To report an adverse event or any drug related issues concerning Novartis medicianal products; please contact Novartis Patient Safety: Tel: +202 22861000 - Press 3 for reporting an adverse event. Fax: 002 02 26031702. E-mail: [email protected]
For safety labels, please click here and follow the below steps:
Enter the name of the product in the search field
Select the result “Human medicine European public assessment report (EPAR)”
In product information section, click the link “EPAR- product information’ to download the last updated section of the EU SmPC